These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31480427)

  • 21. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
    Maclennan AH; Broadbent JL; Lester S; Moore V
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD002978. PubMed ID: 15495039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis.
    Yoon SH; Lee JY; Lee C; Lee H; Kim SN
    Menopause; 2020 Apr; 27(4):485-493. PubMed ID: 32049930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical appraisal of paroxetine for the treatment of vasomotor symptoms.
    Carroll DG; Lisenby KM; Carter TL
    Int J Womens Health; 2015; 7():615-24. PubMed ID: 26124682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study.
    Rotem C; Kaplan B
    Gynecol Endocrinol; 2007 Feb; 23(2):117-22. PubMed ID: 17454163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of paroxetine for the treatment of vasomotor symptoms.
    Slaton RM; Champion MN; Palmore KB
    J Pharm Pract; 2015 Jun; 28(3):266-74. PubMed ID: 25107421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.
    Soares CN; Joffe H; Viguera AC; Petrillo L; Rydzewski M; Yehezkel R; Somley B; Cohen LS
    Am J Med; 2008 Feb; 121(2):159-162.e1. PubMed ID: 18261506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
    Mohammady M; Janani L; Jahanfar S; Mousavi MS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missed symptoms of menopause.
    Warren MP
    Int J Clin Pract; 2007 Dec; 61(12):2041-50. PubMed ID: 17892470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hot flushes in breast and prostate cancer.
    Adelson KB; Loprinzi CL; Hershman DL
    Expert Opin Pharmacother; 2005 Jun; 6(7):1095-106. PubMed ID: 15957964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.
    Constantine GD; Archer DF; Pollycove R; Jiang W; Altomare C; Pinkerton JV
    Menopause; 2016 Sep; 23(9):957-64. PubMed ID: 27404027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment and treatment of hot flushes and menopausal mood disturbance.
    Joffe H; Soares CN; Cohen LS
    Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
    Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
    J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
    Hitchcock CL; Prior JC
    Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials.
    Sun Z; Hao Y; Zhang M
    Gynecol Obstet Invest; 2013; 75(4):255-62. PubMed ID: 23548358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral oestrogen replacement therapy versus placebo for hot flushes.
    MacLennan A; Lester S; Moore V
    Cochrane Database Syst Rev; 2001; (1):CD002978. PubMed ID: 11279791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.